as an index of anxiety/depressive-like behaviors. Food consumption in the home cage for six minutes after the test was used as a measure for appetite after NSF testing and food deprivation.
SP. The sucrose test was performed using a two-bottle choice test between a 2% sucrose solution and water. Mice had free access to both water and a 2% sucrose solution 48 hours before the test in their home cage to reduce neophobia. Following training, for 16 h from 18:00 pm-10:00 am (active phase) and given free access to both water and the 2% sucrose solution. Position of bottles was counterbalanced across the left and the right sides from test to test. Sucrose and water consumption were measured. Sucrose preference (percent) was calculated as follows: preference = [sucrose solution intake (ml)/total fluid intake (ml)] × 100. Sucrose consumption was calculated as: consumption = [sucrose solution intake (ml)/ body weight (g)].
Z-scoring. To assess the consistency of behavioral performance across related tests, emotionalityor locomotion-related data were normalized using a Z-score methodology Physiological Evaluation. The body weight and coat state of all the animals were assessed and scored (0-2 points) weekly by a double-blinded experimenter until the end of the UCMS treatment.
The total score of the coat state resulted from the sum of the score of five different body parts:
head, neck, dorsal and ventral fur, tails and paws. A score of 0 was given for a well-groomed fur and increased to 2 for an unkempt fur.
Corticosterone Measurements. The stress reactivity test consisted of a 30-min restraint period, corresponding to an acute, moderate stressor. The blood samplings were drawn at three time points: immediately before, during a 30-min exposure to restraint stress, as well as 60 min after ending the stress session (recovery period). The animals were restrained in a 50-ml Falcon tube with a ventilation hole and a hole in the lid for the tail. Tail blood (30 μl) was collected into a
Microtainer® tube with Lithium Heparin (BD Vacutainer Systems, Franklin Lakes, NJ) at 10:00-14:00. Bleeding was induced by cutting the tip of the tail, and plasma was separated by centrifugation at 1200 g, 4°C for 10 min, and then stored at -80°C until use. All samples were ran in duplicate and measured by Corticosterone ELISA Kit (EnzoLife Sciences, Farmingdale, NY)
according to the instructions of the manufacturer.
Chronic corticosterone treatment. As described previously, 6 mice were given corticosterone (35 mg/ml; Sigma-C2505, St Louis, MO, USA) dissolved in 20% cyclodextrin (Sigma H107) as their only water supply for 6 weeks. Mice show no aversion to drinking water with corticosterone.
Visualization of individual neurons in mice.
For signle-cell analyses, mice were rapidly transcardially perfused with 1 ml of 1X Tris-buffered saline and 1 ml of 4% paraformaldehyde in phosphate buffer (pH 7.4) to lightly fix tissue while preserving GFP signal and RNA integrity.
Cryostat sections (20 μm) were cut from coronal blocking containing cingulate cortex (between bregma +1.42 to -0.5 mm), thaw-mounted onto on polyethylene napthalate membrane coated slides (Leica Microsystems; #11505158; Bannockburn, IL, USA) that had been treated with UV at 254 nm for 30 min. Before microdissection, slides for SST neurons were dehydrated through 100% ethanol for 10 seconds. For pyramidal neurons, cryostat sections from mice with GFP-tagged SST neurons were dried briefly and stored at -80˚C. Immediately before microdissection, slides were immersed in an ethanol-acetic fixation solution, stained with thionin, dehydrated with 100% ethanol, as described previously. 7 Pyramidal neurons were visually identified based on their location and characteristic somal morphology including pyramidal shape, large size, and thick apical dendrite. Canonical pathway analysis. The Ingenuity Knowledge Base has included 642 well-characterized, canonical pathways that were derived from journal articles, textbooks, and the KEGG database, all manually curated by PhD-level scientists. Canonical pathways that differed most significantly were determined by Fisher's exact test. As a result, a p-value was obtained for determining the probability that the association between our dataset targets and the canonical pathway can be explained by chance. In addition, a ratio was determined by the number of dataset targets that map to the pathway divided by the total number of molecules that exist in the canonical pathway.
Upstream regulator analysis. Based on previous knowledge of expected causal effects between upstream regulators/drugs and their target genes stored in the Ingenuity® Knowledge Base, this analysis predicted which upstream regulators can explain the observed alterations of our dataset targets by Fisher's exact test. As a result, a p-value was obtained for determining the significance of enrichment of network-regulated genes (the dataset targets downstream of an upstream regulator).
Real-time quantitative polymerase chain reaction (qPCR). For molecular phenotypes in mice
with low SST, brains were flash frozen on dry ice after sacrifice. Bilateral cingulate cortex was obtained using a cryostat and a 1-mm-bore tissue punch. Total RNA was extracted using the RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions. Reverse transcription reaction was performed using the qScript cDNA Supermix (Quanta Biosciences, Gaithersburg, MD). were dissolved in 100% dimethyl sulfoxide (DMSO) and later diluted in saline (0.9% NaCl). Based on previous studies, [8] [9] [10] [11] vehicle (10% DMSO/saline), Salubrinal (1.5 mg/kg), and GSK2606414 (30 mg/kg) were administered by oral gavage once daily for 7 days to mice (0.1 ml/10 mg) treated with 3 weeks of UCMS before behavioral testing. Three days of booster administrations were given on the second day after each test. Concentrations were adjusted to administer 10 ml/kg. After 7 days of drug treatments, anxiety/depressive-like behaviors and locomotion were tested in the following order:
EPM, NSF, OF, separated by one day of booster administration. All tests were performed during the light phase of the circadian cycle, between 9 am and 3 pm.
Statistical Analysis. Statistical analyses were carried out using GraphPrism Version 6.0 (Graph Pad. Software Inc., San Diego, CA, USA). Student's t test was used to compare means between two groups, and one-way or two-way analysis of variance followed by Tukey's post hoc among means were used to determine significant differences among multiple groups. All data are expressed as means ± standard error of the mean. CDH1  NME1,RALA,RAB5B,TUBB,CLIP1,ARF6,CTNNA2,EXOC2,ARPC3,TUB  A1C,CTNNB1,ACTN1,TUBB3,TUBB4B,ACTB,TUBB2A,TUBA4A,RAB7A  ,DNM3,ACTG1,TUBA1B,DNM1,TUBA1A,ARPC1A,ARPC2,MAPRE2,AC  TN4,DNM1L,ARPC4,MAPRE3 GABA Receptor Signaling D,MAPK3,DLG4,PLCB1,RASA1,GRM1,IFT57,HSPA9,CLTC,CREBBP,D  NM3,GNG3,STX1A,RPH3A,ATF2,TAF9B,HDAC5,HSPA8,DYNC1I2,DN  AJC5,ATP5B,HTT,POLR2I,SNCA,SDHB,PACSIN1,POLR2B,VTI1B,GN  G7,EP300,POLR2A,PIK3C3,IGF1R,AKT3,PRKCE,NCOR1,NAPB,SDHA  ,GRIN2B,GLS,MAPK8,GNAQ,Hdac9,SNAP25,ZDHHC17,GRM5,POLR2  L,DNM1,PRKCI,DCTN1,STX16,GNG5, PTPN4,  GYS2,  PDE6B,  TNNI2,PDE  12,TCF7L1,  TGFB2,  PDE6G,  TNNI3,  TCF3,  MYL10,  LEF1,  H2BFM,  NTN1,  PPP1R3D,  GNG12   MYH10,MYL6,PTPN5,GNB1,CAMK2A,PLCB1,DUSP7,NFKBIB , Fragile X mental retardation 1 (FMR1) 9.41E-16
Up Down
Sst-expressing neurons treated with chronic corticosterone relative to non-stressed neurons.
Genes were tested for differential expression between corticosterone-treated and control groups.
Statistical significance for differential expression was reached at fold-change > 20% and p<0.05.
The resulting signature was submitted to IPA to test for over-representation of canonical pathways.
The p-value was calculated by right-tailed Fisher's exact tests (Fisher 1922) . The ratio was calculated by the number of differentially expressed genes, divided by total number of genes that make up in a given pathway.
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